These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 21896761)
21. Selection of antibody single-chain variable fragments with improved carbohydrate binding by phage display. Deng SJ; MacKenzie CR; Sadowska J; Michniewicz J; Young NM; Bundle DR; Narang SA J Biol Chem; 1994 Apr; 269(13):9533-8. PubMed ID: 8144539 [TBL] [Abstract][Full Text] [Related]
22. Functional mapping of conserved residues located at the VL and VH domain interface of a Fab. Chatellier J; Van Regenmortel MH; Vernet T; Altschuh D J Mol Biol; 1996 Nov; 264(1):1-6. PubMed ID: 8950262 [TBL] [Abstract][Full Text] [Related]
23. Ribosome display efficiently selects and evolves high-affinity antibodies in vitro from immune libraries. Hanes J; Jermutus L; Weber-Bornhauser S; Bosshard HR; Plückthun A Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14130-5. PubMed ID: 9826665 [TBL] [Abstract][Full Text] [Related]
24. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain. Chen Y; Stollar BD J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006 [TBL] [Abstract][Full Text] [Related]
25. Analysis of IgE antibodies from a patient with atopic dermatitis: biased V gene usage and evidence for polyreactive IgE heavy chain complementarity-determining region 3. Edwards MR; Brouwer W; Choi CH; Ruhno J; Ward RL; Collins AM J Immunol; 2002 Jun; 168(12):6305-13. PubMed ID: 12055246 [TBL] [Abstract][Full Text] [Related]
26. Heavy and light chain variable single domains of an anti-DNA binding antibody hydrolyze both double- and single-stranded DNAs without sequence specificity. Kim YR; Kim JS; Lee SH; Lee WR; Sohn JN; Chung YC; Shim HK; Lee SC; Kwon MH; Kim YS J Biol Chem; 2006 Jun; 281(22):15287-95. PubMed ID: 16551636 [TBL] [Abstract][Full Text] [Related]
27. A comparative analysis of the immunological evolution of antibody 28B4. Yin J; Mundorff EC; Yang PL; Wendt KU; Hanway D; Stevens RC; Schultz PG Biochemistry; 2001 Sep; 40(36):10764-73. PubMed ID: 11535051 [TBL] [Abstract][Full Text] [Related]
28. Simultaneous assessment of Asp isomerization and Asn deamidation in recombinant antibodies by LC-MS following incubation at elevated temperatures. Diepold K; Bomans K; Wiedmann M; Zimmermann B; Petzold A; Schlothauer T; Mueller R; Moritz B; Stracke JO; Mølhøj M; Reusch D; Bulau P PLoS One; 2012; 7(1):e30295. PubMed ID: 22272329 [TBL] [Abstract][Full Text] [Related]
29. Decreased amyloidogenicity caused by mutational modulation of surface properties of the immunoglobulin light chain BRE variable domain. Kobayashi Y; Tsutsumi H; Abe T; Ikeda K; Tashiro Y; Unzai S; Kamikubo H; Kataoka M; Hiroaki H; Hamada D Biochemistry; 2014 Aug; 53(31):5162-73. PubMed ID: 25062800 [TBL] [Abstract][Full Text] [Related]
30. Antibody engineering reveals the important role of J segments in the production efficiency of llama single-domain antibodies in Saccharomyces cerevisiae. Gorlani A; Hulsik DL; Adams H; Vriend G; Hermans P; Verrips T Protein Eng Des Sel; 2012 Jan; 25(1):39-46. PubMed ID: 22143875 [TBL] [Abstract][Full Text] [Related]
31. RosettaAntibody: antibody variable region homology modeling server. Sircar A; Kim ET; Gray JJ Nucleic Acids Res; 2009 Jul; 37(Web Server issue):W474-9. PubMed ID: 19458157 [TBL] [Abstract][Full Text] [Related]
32. Predicting the expression of recombinant monoclonal antibodies in Chinese hamster ovary cells based on sequence features of the CDR3 domain. Pybus LP; James DC; Dean G; Slidel T; Hardman C; Smith A; Daramola O; Field R Biotechnol Prog; 2014; 30(1):188-97. PubMed ID: 24311306 [TBL] [Abstract][Full Text] [Related]
34. Mutation of a single conserved residue in VH complementarity-determining region 2 results in a severe Ig secretion defect. Wiens GD; Lekkerkerker A; Veltman I; Rittenberg MB J Immunol; 2001 Aug; 167(4):2179-86. PubMed ID: 11490003 [TBL] [Abstract][Full Text] [Related]
35. The structure of the anti-c-myc antibody 9E10 Fab fragment/epitope peptide complex reveals a novel binding mode dominated by the heavy chain hypervariable loops. Krauss N; Wessner H; Welfle K; Welfle H; Scholz C; Seifert M; Zubow K; Aÿ J; Hahn M; Scheerer P; Skerra A; Höhne W Proteins; 2008 Nov; 73(3):552-65. PubMed ID: 18473392 [TBL] [Abstract][Full Text] [Related]
36. Development of a human light chain variable domain (V(L)) intracellular antibody specific for the amino terminus of huntingtin via yeast surface display. Colby DW; Garg P; Holden T; Chao G; Webster JM; Messer A; Ingram VM; Wittrup KD J Mol Biol; 2004 Sep; 342(3):901-12. PubMed ID: 15342245 [TBL] [Abstract][Full Text] [Related]
37. Unraveling the effect of changes in conformation and compactness at the antibody V(L)-V(H) interface upon antigen binding. Pellequer JL; Chen Sw; Roberts VA; Tainer JA; Getzoff ED J Mol Recognit; 1999; 12(4):267-75. PubMed ID: 10440998 [TBL] [Abstract][Full Text] [Related]
38. Molecular modeling and site-directed mutagenesis of an anti-phosphotyrosine antibody predicts the combining site and allows the detection of higher affinity interactions. Ruff-Jamison S; Glenney JR Protein Eng; 1993 Aug; 6(6):661-8. PubMed ID: 7694275 [TBL] [Abstract][Full Text] [Related]
39. Domain interactions in antibody Fv and scFv fragments: effects on unfolding kinetics and equilibria. Jäger M; Plückthun A FEBS Lett; 1999 Dec; 462(3):307-12. PubMed ID: 10622716 [TBL] [Abstract][Full Text] [Related]
40. A disulfide-free single-domain V(L) intrabody with blocking activity towards huntingtin reveals a novel mode of epitope recognition. Schiefner A; Chatwell L; Körner J; Neumaier I; Colby DW; Volkmer R; Wittrup KD; Skerra A J Mol Biol; 2011 Dec; 414(3):337-55. PubMed ID: 21968397 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]